SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bernard, G.
Right arrow Articles by Shevell, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, G.
Right arrow Articles by Shevell, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Dosage Effect of a Dominant CLCN1 Mutation: A Novel Syndrome

Geneviève Bernard, MD, MSc

Departments of Neurology/Neurosurgery and Pediatrics, McGill University Health Center, Montreal

Chantal Poulin, MD, FRCP C

Departments of Neurology/Neurosurgery and Pediatrics, McGill University Health Center, Montreal

Jack Puymirat, MD, FRCP C

Centre de recherche du CHUL - Université Laval, Sainte-Foy, Quebec, Canada

Damien Sternberg, MD, PhD

Service de Biochimie, Hôpital Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, Paris, France

Michael Shevell, MD, FRCP C

Departments of Neurology/Neurosurgery and Pediatrics, McGill University Health Center, Montreal, michael.shevell{at}muhc.mcgill.ca

Multiple mutations in the CLCN1 gene coding for the voltage-gated chloride channel have been documented to cause myotonia congenita. We report a kindred featuring an index patient who possesses 2 copies of a dominantly inherited mutated CLCN1 allele with a resulting novel phenotypic presentation. The index patient is a boy who presented initially for evaluation at the age of 5 years with a 2-year history of gait problems. Both parents and 3 male siblings were entirely well. Examination revealed a striking diffuse muscular hypertrophy, diffuse mild to moderate weakness, Gower sign, percussion, and grip myotonia. Electromyography confirmed myotonia, and molecular analysis revealed 2 copies of the T310M mutation on the CLCN1 gene. Testing of family members revealed a normal neurological examination without clinical myotonia in all and electromyographic evidence of myotonia and a single copy of the T310M mutation in both parents and 2 siblings. Our kindred is the initial demonstration of the dosage effect of a dominant mutated allele in the CLCN1 gene.

Key Words: myotonia congenita • CLCN1 • channelopathy

Journal of Child Neurology, Vol. 23, No. 2, 163-166 (2008)
DOI: 10.1177/0883073807307974


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement